{"name":"GlycoMimetics Incorporated","slug":"glycomimetics-incorporated","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"GMI-1070","genericName":"GMI-1070","slug":"gmi-1070","indication":"Acute myeloid leukemia","status":"phase_2"}]}],"pipeline":[{"name":"GMI-1070","genericName":"GMI-1070","slug":"gmi-1070","phase":"phase_2","mechanism":"Inhibits the selectin family of adhesion molecules","indications":["Acute myeloid leukemia"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwAJBVV95cUxPV1lFZFBJRTc2UGhsallqajFaVTBycEhab1JxTWdkc1VmOGMycWJLdkstbXNTM0c0YWpxX0E1ajdxZDZCNEwtOXBpVVV5VVNqa2JybThTbTVSNmJ3blh5RkdPR0lOR2tyUXBTYVZaa1htQUhEbTNhbWFtcVBtNklVRldHYm9Odm5HaU5fNHhSS2JPbGc1ZEZIS3d1REpXNkNzRkd0TnBDak1LYUtTaWVWMVI1UUVZQ3BQazVFM1B1RGJsby10YUpfdlVxa1ZMc3hZVjNvUmg0NHgxLUZyeTJwODRyQ1hFeDJ4VllsWFhTOTBrOEhMZUtSVXBYamxRMkN0b3pqN05tNmFkbmQzeDNDNE9mTWtDaWN3Y0tnMnNnY1Q0SlM2aTBFY0ZVU1lwSFQ1SVQ2cE5ORXp1bnBwY0V2cw?oc=5","date":"2025-07-15","type":"regulatory","source":"PR Newswire","summary":"Menin Inhibitors Market Forecasts Signal Strong Uptake of Menin Inhibitors in Hematologic Oncology Across the 7MM During the Forecast Period (2020-2034) | DelveInsight - PR Newswire","headline":"Menin Inhibitors Market Forecasts Signal Strong Uptake of Menin Inhibitors in Hematologic Oncology Across the 7MM During","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxNWDJjOFVpTlF6aFAtdzJaQnhleEptanI5dm1jZ2U3NkxpUVVMcjdrb0ZQXzRiV3BidlJXSS1QZVQzVEN1Njk1YU1lTGplWmU1RC1EeENhVDJET2FDSVFZNTFiWV9NeFo3YTAyQTRXV3JvbHNTY1EzTzV0Y1FyRFoydHh2RC10Tm9KdVZTNU9SbWM5MXpEdzJ2cG9zd1BMZjJ1VGpNeS0tWHJWOGpXelRialV5cmhydTFicXNoWmxLSTh2b1ltWVJGTm1OaXE3YVF6dksxeHNvbGNtalhLXzFidFVGZ2MwSkJF?oc=5","date":"2025-04-08","type":"pipeline","source":"PR Newswire","summary":"TIBSOVO's Continued Success Solidifies Its Position as a Leader in IDH1 Mutant Space | DelveInsight - PR Newswire","headline":"TIBSOVO's Continued Success Solidifies Its Position as a Leader in IDH1 Mutant Space | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOY1Etemt1RjFETUQzQ3lLZHBnWXdFaXZfUnBqVldjbjFNZEdmc2FvMjU3NlpWeWZoUmVEVUJYM0RFX0lxRzVVOTFiSlEwU1AxUmhTS0l4LUV0RDNLZENYb3VXUFM3Wi1aX0EyZFVKY2NsdEdGUDhkUUNWVGV0WWduOEdDYWYwWFVPR3VvSUlKeHJCY2lyanoxMXFnenBVc2g4VV9kTFV6YmkxZmhpaGhVSkRzdXRYS1MydEZydmxNaXlwUDBEUEln?oc=5","date":"2024-10-29","type":"pipeline","source":"Business Wire","summary":"GlycoMimetics Enters Into Acquisition Agreement With Crescent Biopharma - Business Wire","headline":"GlycoMimetics Enters Into Acquisition Agreement With Crescent Biopharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNLUNhMjU3X0dLNDd3b3ZXbmx2cjRkenFSZk9FbWw2T0N2ZVNJVUVWb3c0WHA2ckxaSHlUbXoweFZjSkp4d2NPUWZOZENhOVFtaG1FdTEtUk1fcTlfLTBPTW5vSF9rM2FSTzItNEpUZVlFNHlGRDJ1bURGQUJ6ZFB5YlNGZ2pHXy1TcjB4cWk3d2UwS0RXcXI0QWRTZ2VZekx2WmhPcmdVQ2NVdG5tYXBR?oc=5","date":"2024-10-29","type":"pipeline","source":"BioPharma Dive","summary":"Paragon spinout joins hunt for new type of cancer immunotherapy - BioPharma Dive","headline":"Paragon spinout joins hunt for new type of cancer immunotherapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxNbDVNY2Vtekhac0k0RU5Rc0hGN3FTVFA2UTRaMlRvbnduYW54TEtEUFpmdjIzYWUxQ1k1Rmt4R3JtVEtPTkFQMWRhTmxtOEctdGJMN0RCSlJ2dWxsWWRkN0xucC1ETkxZSnhEX0JEeGZVTXpTMjZSeDJwbWphbGRQa3lNTEFkTG5XOUZDZ1ZSa0JXWFlUbGFhRDZ0M29QSlIxQUg1Rk8wMXlUUEFEWG5CQndyS0tDQVp2T2tmM0lzeTZRSEtIbk1DVzY3ZWVpX0RZcWJ6MWtSS0FJd21JTTNwVXcxeHpBSXJlVHl3MmIxMUtlQWVLaVlfTVhvWUdobkRiVDFTM0pkWTFYSHo4RjN3TU1VYUV5dk1XZjRya3ptcUwwREpUamVveE9QYU4zSUxSU3djOWZNTQ?oc=5","date":"2024-10-01","type":"trial","source":"GlobeNewswire","summary":"Breast Cancer Clinical Trial Pipeline Appears Robust With - GlobeNewswire","headline":"Breast Cancer Clinical Trial Pipeline Appears Robust With","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}